Cambridge Healthtech Institute’s 9th Annual

Cell Therapy Manufacturing

August 16-17, 2023

CHI’s Cell Therapy Manufacturing conference examines the practical challenges in manufacturing autologous and allogenic cell therapies at scale, with dedicated sessions on cell processing, scalability, next-generation production technologies, automation, closed systems, artificial intelligence, supply chain, and facility design. The meeting takes examples from autologous and allogeneic therapies and the field of CAR Ts, NK cells, Gamma Deltas, TCRs, TILs and IPSCs.

Coverage will include, but is not limited to:

Commerical scale manufacturing
Rapid testing at scale
New approaches to CAR T manufacturing
Reducing vein-to-vein administration, hospital settings
Autologous manufacturing strategies
Allogeneic manufacturing strategies
Automated, closed, and integrated systems
CMO strategy, centralized, and de-centralized manufacturing networks
Operations and logistics
In vivo cellular engineering
Internal versus external manufacturing
Supply chain security

The deadline for priority consideration is February 3, 2023.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: